Biosynex (XPAR:ALBIO) FCF Margin % : -98.67% (As of Jun. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Biosynex FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biosynex's Free Cash Flow for the six months ended in Jun. 2023 was €-42.09 Mil. Biosynex's Revenue for the six months ended in Jun. 2023 was €42.65 Mil. Therefore, Biosynex's FCF Margin % for the quarter that ended in Jun. 2023 was -98.67%.

As of today, Biosynex's current FCF Yield % is -127.29%.

The historical rank and industry rank for Biosynex's FCF Margin % or its related term are showing as below:

XPAR:ALBIO' s FCF Margin % Range Over the Past 10 Years
Min: -55.64 Med: 14.63 Max: 23.74
Current: -55.64

During the past 13 years, the highest FCF Margin % of Biosynex was 23.74%. The lowest was -55.64%. And the median was 14.63%.

XPAR:ALBIO's FCF Margin % is ranked worse than
72.28% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: -7.11 vs XPAR:ALBIO: -55.64

Biosynex FCF Margin % Historical Data

The historical data trend for Biosynex's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosynex FCF Margin % Chart

Biosynex Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

14.63

23.74

-12.79

Biosynex Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial															29.95	14.86	-9.32	-21.87	-98.67

Competitive Comparison of Biosynex's FCF Margin %

For the Medical Devices subindustry, Biosynex's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosynex's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biosynex's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biosynex's FCF Margin % falls into.

Biosynex FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biosynex's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-25.135	/	196.587
	=	-12.79 %

Biosynex's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-42.086	/	42.653
	=	-98.67 %

Biosynex FCF Margin % Related Terms

Thank you for viewing the detailed overview of Biosynex's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosynex (XPAR:ALBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biosynex SA (XPAR:ALBIO) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

0DL:Germany

Address

22 Boulevard Sebastien Brant, Illkirch, FRA, 67400

Website

http://www.biosynex.com

Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.

Biosynex (XPAR:ALBIO) Headlines

No Headlines